Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell
• ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Why Kura Oncology Stock Is Moving Higher Tuesday Morning
Kura Oncology Inc (NASDAQ: KURA) shares are trading higher Tuesday after the company announced the FDA clearance of its Inve
Cramer Is Holding This Biotech Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN).
On Saturday December 10th Kura Oncology Presents Updated Clinical Data From KOMET-001 Trial Of Menin Inhibitor Ziftomenib At American Society Of Hematology Annual Meeting
– 30% CR rate at 600 mg in 20 patients with relapsed/refractory NPM1-mutant AML –
– Low frequency of differentiation syndrome, including 5% rate (1/20) of ≥ Grade 3 among
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Earnings Preview: Kura Oncology
Kura Oncology (NASDAQ:KURA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement.
Analysts estimate that Kura Oncology will report an earnings per share (EPS) of $-0.52.
Read Why Did Credit Suisse Raise Price Target On Kura Oncology
Credit Suisse has raised the price target on Kura Oncology Inc (NASDAQ:KURA) to $29 from $27. The analysts say that evidence of an…
Credit Suisse Maintains Outperform on Kura Oncology, Raises Price Target to $29
Credit Suisse analyst Tiago Fauth maintains Kura Oncology (NASDAQ:KURA) with a Outperform and raises the price target from $27 to $29.